$227 Million is the total value of Integral Health Asset Management, LLC's 51 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 122.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDT | Buy | MEDTRONIC PLC | $10,371,000 | -12.9% | 115,000 | +9.5% | 4.57% | -1.5% |
| CNC | Buy | CENTENE CORP DEL | $10,100,000 | +28.5% | 170,000 | +36.0% | 4.45% | +45.4% |
| MRK | New | MERCK & CO. INC | $10,002,000 | – | 130,000 | +100.0% | 4.41% | – |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $9,755,000 | -20.0% | 175,000 | -7.9% | 4.30% | -9.5% |
| DGX | Buy | QUEST DIAGNOSTICS INC | $9,636,000 | +12.8% | 120,000 | +50.0% | 4.24% | +27.6% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $9,295,000 | -0.1% | 110,000 | 0.0% | 4.09% | +13.0% | |
| AZN | New | ASTRAZENECA PLCsponsored adr | $8,485,000 | – | 190,000 | +100.0% | 3.74% | – |
| CTLT | New | CATALENT INC | $7,793,000 | – | 150,000 | +100.0% | 3.43% | – |
| CCXI | Buy | CHEMOCENTRYX INC | $7,634,000 | +285.9% | 190,000 | +280.0% | 3.36% | +336.8% |
| EHC | New | ENCOMPASS HEALTH CORP | $7,363,000 | – | 115,000 | +100.0% | 3.24% | – |
| LHCG | New | LHC GROUP INC | $7,010,000 | – | 50,000 | +100.0% | 3.09% | – |
| DHR | New | DANAHER CORPORATION | $6,921,000 | – | 50,000 | +100.0% | 3.05% | – |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $6,568,000 | +214.1% | 75,000 | +275.0% | 2.89% | +255.4% |
| MASI | New | MASIMO CORP | $6,199,000 | – | 35,000 | +100.0% | 2.73% | – |
| NVS | New | NOVARTIS A Gsponsored adr | $5,772,000 | – | 70,000 | +100.0% | 2.54% | – |
| BDX | New | BECTON DICKINSON & CO | $5,744,000 | – | 25,000 | +100.0% | 2.53% | – |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $5,322,000 | -41.3% | 150,000 | -21.1% | 2.34% | -33.7% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $4,882,000 | -43.6% | 170,000 | +41.7% | 2.15% | -36.3% |
| EXAS | New | EXACT SCIENCES CORP | $4,640,000 | – | 80,000 | +100.0% | 2.04% | – |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $4,620,000 | +45.3% | 110,000 | +57.1% | 2.04% | +64.4% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $4,079,000 | -54.9% | 125,000 | -37.5% | 1.80% | -49.0% |
| NVRO | New | NEVRO CORP | $3,999,000 | – | 40,000 | +100.0% | 1.76% | – |
| XRAY | New | DENTSPLY SIRONA INC | $3,883,000 | – | 100,000 | +100.0% | 1.71% | – |
| CYTK | New | CYTOKINETICS INC | $3,773,000 | – | 320,000 | +100.0% | 1.66% | – |
| CHWY | New | CHEWY INCcl a | $3,749,000 | – | 100,000 | +100.0% | 1.65% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $3,660,000 | – | 80,000 | +100.0% | 1.61% | – |
| ABT | New | ABBOTT LABS | $3,551,000 | – | 45,000 | +100.0% | 1.56% | – |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $3,509,000 | +119.0% | 60,000 | +200.0% | 1.55% | +147.8% |
| ISRG | New | INTUITIVE SURGICAL INC | $3,466,000 | – | 7,000 | +100.0% | 1.53% | – |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $3,398,000 | -22.9% | 185,000 | -7.5% | 1.50% | -12.8% |
| PKI | New | PERKINELMER INC | $3,388,000 | – | 45,000 | +100.0% | 1.49% | – |
| MCK | New | MCKESSON CORP | $3,382,000 | – | 25,000 | +100.0% | 1.49% | – |
| NVO | Buy | NOVO-NORDISK A Sadr | $3,311,000 | +43.0% | 55,000 | +37.5% | 1.46% | +61.8% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $3,075,000 | +59.1% | 40,000 | +166.7% | 1.35% | +79.8% |
| EXEL | New | EXELIXIS INC | $2,583,000 | – | 150,000 | +100.0% | 1.14% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $2,494,000 | – | 10,000 | +100.0% | 1.10% | – |
| TXG | Buy | 10X GENOMICS INC | $2,493,000 | +30.8% | 40,000 | +60.0% | 1.10% | +48.0% |
| ALKS | New | ALKERMES PLC | $2,163,000 | – | 150,000 | +100.0% | 0.95% | – |
| FATE | New | FATE THERAPEUTICS INC | $2,110,000 | – | 95,000 | +100.0% | 0.93% | – |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $1,921,000 | -71.0% | 100,000 | -71.0% | 0.85% | -67.1% |
| New | EXELIXIS INC | $1,722,000 | – | 100,000 | +100.0% | 0.76% | – | |
| BMYRT | Sell | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $1,710,000 | +3.3% | 450,000 | -18.2% | 0.75% | +16.7% |
| ARVN | New | ARVINAS INC | $1,612,000 | – | 40,000 | +100.0% | 0.71% | – |
| DNLI | New | DENALI THERAPEUTICS INC | $1,576,000 | – | 90,000 | +100.0% | 0.69% | – |
| HUM | Sell | HUMANA INC | $1,570,000 | -81.4% | 5,000 | -78.3% | 0.69% | -78.9% |
| AKBA | New | AKEBIA THERAPEUTICS INC | $1,516,000 | – | 200,000 | +100.0% | 0.67% | – |
| NERV | Buy | MINERVA NEUROSCIENCES INC | $1,505,000 | +17.6% | 250,000 | +38.9% | 0.66% | +33.1% |
| AKRO | New | AKERO THERAPEUTICS INC | $1,272,000 | – | 60,000 | +100.0% | 0.56% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $900,000 | – | 50,000 | +100.0% | 0.40% | – |
| New | AMARIN CORP PLC | $800,000 | – | 200,000 | +100.0% | 0.35% | – | |
| PFNX | New | PFENEX INC | $750,000 | – | 85,000 | +100.0% | 0.33% | – |
| DTIL | Exit | PRECISION BIOSCIENCES INC | $0 | – | -50,000 | -100.0% | -0.27% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -60,000 | -100.0% | -0.36% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -35,000 | -100.0% | -0.42% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -20,000 | -100.0% | -0.53% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -30,000 | -100.0% | -0.61% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -15,000 | -100.0% | -0.63% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -75,000 | -100.0% | -0.63% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.65% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -10,000 | -100.0% | -0.80% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -25,000 | -100.0% | -0.85% | – |
| MYL | Exit | MYLAN N V | $0 | – | -130,000 | -100.0% | -1.02% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -75,000 | -100.0% | -1.11% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -65,000 | -100.0% | -1.15% | – |
| BHC | Exit | BAUSCH HEALTH COS INC | $0 | – | -100,000 | -100.0% | -1.16% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -35,000 | -100.0% | -1.20% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -30,000 | -100.0% | -1.34% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -175,000 | -100.0% | -1.46% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -55,000 | -100.0% | -1.54% | – |
| SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -90,000 | -100.0% | -1.54% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -70,000 | -100.0% | -2.13% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -80,000 | -100.0% | -2.41% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -50,000 | -100.0% | -2.56% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -100,000 | -100.0% | -2.89% | – |
| TFX | Exit | TELEFLEX INC | $0 | – | -21,000 | -100.0% | -3.08% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -95,000 | -100.0% | -3.28% | – |
| VAR | Exit | VARIAN MED SYS INC | $0 | – | -60,000 | -100.0% | -3.32% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -190,000 | -100.0% | -3.71% | – |
| AMED | Exit | AMEDISYS INC | $0 | – | -65,000 | -100.0% | -4.22% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -60,000 | -100.0% | -5.11% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -170,000 | -100.0% | -5.65% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.